CClinicalTrials.gg
Status unknownNCT05575414Updated Jan 10, 2023

Diet Versus Control Pregnant Barbadian Women Gestational Weight Gain Trial

An interventional study of Didactic dietary sessions and Education Tool in Obesity, Gestational Weight Gain and Obesity, Maternal, sponsored by The University of The West Indies. Status unknown. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-10.

Sponsored by The University of The West Indies · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
172
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The researcher will study a group of pregnant Barbadians with BMI at booking of greater than or equal to 35. All of the women will be given leaflets telling them about healthy diets in pregnancy and how to limit weight gain. Half of the women will be sent to the dietitian for small group classes on diet and how to limit weight gain. The two groups of women will be compared to see which group gains more weight and which group has more complications during the pregnancy.

Read the detailed description

More than 2100 pregnant women per annum deliver their babies at the Queen Elizabeth Hospital, the lone publicly-funded hospital providing secondary and tertiary-level obstetric care in Barbados. Routinely recorded data do not capture whether patients are overweight or obese. Thus, the prevalence of obesity is not known amongst this population. Additionally, these women are not routinely referred for dietician services, and thus the impact of dietician intervention is not known. The aim of this research is to determine whether a dietitian-led intervention could lead to decreased gestational weight gain and less incidence of foetal macrosomia in a sample of Barbadian women, with class II obesity, attending a public antenatal clinic. Prior studies examining gestational weight gain, found no statistically significance between groups when a BMI of 30 was used. It is hoped that by using a group with higher obesity a larger difference will be seen with the intervention. Participants with body mass index greater than 35kg/m\^2 who meet the eligibility criteria will be selected from one of five antenatal clinics at the Queen Elizabeth Hospital on the island of Barbados. They will be randomised to either receive didactic dietary sessions or a standard education tool. Mean weight change will be compared amongst the two groups after delivery to determine if there was a decrease in gestational weight gain amongst the intervention group.

02

Conditions studied

  • Obesity
  • Gestational Weight Gain
  • Obesity, Maternal

Keywords

  • Obesity
  • Gestational Weight Gain
  • Pregnancy
  • Afro-Caribbean
  • Barbadian
  • Barbados
03

In context

Obesity, Maternal

36 studies on the registry are indexed under Obesity, Maternal; 7 are open to participants now.

This study's planned enrollment of 172 is above the median of 100 across 21 interventional studies indexed under Obesity, Maternal.

Browse Obesity, Maternal studies →

Lead sponsor

The University of The West Indies is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Woman over 18 years old
  • Live singleton pregnancy
  • BMI of greater than or equal to 35kg/m\^2
  • Registered patient of the Queen Elizabeth Hospital Antenatal Clinic

Exclusion criteria

Exclusion Criteria:

  • Presence of gestational diabetes or chronic diabetes mellitus,
  • Have had bariatric surgery
  • Do not speak english
  • Pregnancy with a multiple gestation.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
172 participants (estimated)

Study arms

  • Experimental
    Didactic Sessions

    Women will receive online nutrition education by a registered dietitian, in addition to the same standard patient education tool as the other arm.

    Behavioral: Didactic dietary sessions · Behavioral: Education Tool

  • Experimental
    Education Tool

    Women will receive a standard patient education tool in the form of a leaflet.

    Behavioral: Education Tool

Interventions

  • BehavioralDidactic dietary sessions

    Three one-hour online nutrition group classes will be scheduled at 17, 21 and 29 weeks gestation (± 1 week). Nutrient dense foods and beverages and limiting the intake of added sugars, sodium and saturated fat will be encouraged, as well as reading the nutrition facts label, individual goal setting and self-monitoring. Physician recommended physical activity will be encouraged. Food and beverage intake data will be measured by 24-hour dietary recalls collected on three non-consecutive days. Data will be collected by telephone interview by a registered dietitian or dietary technician on four separate occasions: 16, 20 and 28 weeks gestation (± 1 week) and 36 weeks of gestation. Details on portions consumed will be estimated using standard measuring cups and household utensils. Nutrient intake will be generated using Vision Software Nutrient Analysis Software and the United States Department of Agriculture Food Composition Database, Food Data Central.

  • BehavioralEducation Tool

    The standard patient education tool will take the form of a leaflet which will include 1. A definition of body mass index 2. A list of measures to be taken to limit weight gain in pregnancy. 3. A description of the major nutrients required in pregnancy (folate, iron, calcium, vitamin D and protein). and 4.A description of the six food groups with recommendations for the number of servings per day.

06

What researchers measure

Primary outcomes

  1. Mean change in gestational weight in kilograms in each arm of the trial

    Weight at or before delivery minus weight at enrolment

    Time frame: From enrolment until delivery

Secondary outcomes

  1. Mean neonatal birth weight in grams in each arm of the trial

    Weight of the neonate at birth

    Time frame: Within one hour of birth

  2. Incidence of pregnancy induced hypertension in each arm of the trial

    New hypertension presenting after 20 weeks of pregnancy without significant proteinuria

    Time frame: Beyond 20 weeks gestation and prior to delivery

  3. Incidence of gestational diabetes in each arm of the trial

    Defined using the National Diabetes Data Group (NDDG) criteria, which uses fasting, 1-hour, 2-hour, and 3-hour plasma glucose levels of 5.8mmol/L, 10.6mmol/L, 9.2mmol/L and 8.1mmol/L respectively diagnosed after 20 weeks gestation

    Time frame: Beyond 20 weeks gestation and prior to delivery

  4. Incidence of primary post partum haemorrhage in each arm of the trial

    The loss of 500 milliliters or more of blood from the genital tract within 24 hours of the birth of a baby. Postpartum haemorrhage will be further subclassified as minor (blood loss 500-1000 ml) or major (blood loss more than 1000 ml)27. Major postpartum haemorrhage will also be subdivided into moderate (1001-2000 ml) and severe (more than 2000 ml).

    Time frame: Within 24 hours of delivery

  5. Incidence of low one minute APGAR score in each arm of the trial

    Defined as a score less than seven

    Time frame: After one minute of birth

Other outcomes

  1. Rates of the various modes of delivery

    A qualitative variable described as vaginal delivery, assisted vaginal delivery or caesarean section and obtained from the patient's labour record

    Time frame: At time of delivery

  2. Rates of Augmentation or Induction of labour

    Augmentation of labour. Induction of labour

    Time frame: At the time of delivery

  3. Rates of preterm birth

    Birth before 37 completed weeks of pregnancy

    Time frame: From enrolment until delivery

  4. Rates of admission to Neonatal Intensive Care Unit

    A qualitative variable described as admitted or not admitted to the neonatal intensive care unit and obtained from the participant's infant medical record

    Time frame: From birth to one week of life

  5. Rates of the presence of foetal malformation

    A qualitative variable described as malformation present or not present and obtained form the participant's infant medical record

    Time frame: From enrolment until delivery

  6. Rates of foetal death

    A qualitative variable described as foetus dead or alive and obtained from the medical record of the participant or the medical record of the participant's infant.

    Time frame: From enrolment until delivery

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Satpathy HK, Fleming A, Frey D, Barsoom M, Satpathy C, Khandalavala J. Maternal obesity and pregnancy. Postgrad Med. 2008 Sep 15;120(3):E01-9. doi: 10.3810/pgm.2008.09.1920. PubMed 18824817 ↗
  • Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007 Aug;30(8):2070-6. doi: 10.2337/dc06-2559a. Epub 2007 Apr 6. PubMed 17416786 ↗
  • Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLoS One. 2013 Apr 16;8(4):e61627. doi: 10.1371/journal.pone.0061627. Print 2013. PubMed 23613888 ↗
  • Marchi J, Berg M, Dencker A, Olander EK, Begley C. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev. 2015 Aug;16(8):621-38. doi: 10.1111/obr.12288. Epub 2015 May 28. PubMed 26016557 ↗
  • Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014 Apr 16;311(15):1536-46. doi: 10.1001/jama.2014.2269. PubMed 24737366 ↗
  • Wolff S, Legarth J, Vangsgaard K, Toubro S, Astrup A. A randomized trial of the effects of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant women. Int J Obes (Lond). 2008 Mar;32(3):495-501. doi: 10.1038/sj.ijo.0803710. Epub 2008 Jan 29. PubMed 18227847 ↗
  • Vinter CA, Jensen DM, Ovesen P, Beck-Nielsen H, Jorgensen JS. The LiP (Lifestyle in Pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese pregnant women. Diabetes Care. 2011 Dec;34(12):2502-7. doi: 10.2337/dc11-1150. Epub 2011 Oct 4. PubMed 21972411 ↗
  • Lima Ferreira J, Voss G, Doria M, Sa Couto A, Principe RM. Benefit of insufficient gestational weight gain in obese women with gestational diabetes mellitus: A multicenter study in Portugal. Diabetes Metab Syndr. 2021 Jan-Feb;15(1):419-424. doi: 10.1016/j.dsx.2021.01.020. Epub 2021 Feb 8. PubMed 33582580 ↗
  • Olander EK, Hill B, Skouteris H. Healthcare Professional Training Regarding Gestational Weight Gain: Recommendations and Future Directions. Curr Obes Rep. 2021 Jun;10(2):116-124. doi: 10.1007/s13679-021-00429-x. Epub 2021 Feb 20. PubMed 33609271 ↗
  • Poston L, Bell R, Croker H, Flynn AC, Godfrey KM, Goff L, Hayes L, Khazaezadeh N, Nelson SM, Oteng-Ntim E, Pasupathy D, Patel N, Robson SC, Sandall J, Sanders TA, Sattar N, Seed PT, Wardle J, Whitworth MK, Briley AL; UPBEAT Trial Consortium. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77. doi: 10.1016/S2213-8587(15)00227-2. Epub 2015 Jul 9. PubMed 26165396 ↗
  • Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines; Rasmussen KM, Yaktine AL, editors. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US); 2009. Available from http://www.ncbi.nlm.nih.gov/books/NBK32813/ PubMed 20669500 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05575414
Lead sponsor
The University of The West Indies
Responsible party
Tonya Johnson (Doctor, The University of The West Indies) — Principal investigator
First posted
Oct 12, 2022
Start date
Jan 2023 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Jan 10, 2023

Study contacts

Tonya C Johnson, MBBS
Contact
obesityinpregnancystudy@gmail.com
4366450
Damian AJ Best, DM MRCOG MSc
study director · University of the West Indies Cave hill Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion